Tekla Healthcare Investors Stock Forecast, Price & News

-0.18 (-0.70 %)
(As of 06/11/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume89,490 shs
Average Volume151,900 shs
Market Capitalization$1.14 billion
P/E RatioN/A
Dividend Yield7.72%
30 days | 90 days | 365 days | Advanced Chart
Receive HQH News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Healthcare Investors and its competitors with MarketBeat's FREE daily newsletter.

About Tekla Healthcare Investors

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.81 out of 5 stars

Finance Sector

1288th out of 1,975 stocks

Investment Offices, Not Elsewhere Classified Industry

86th out of 176 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Tekla Healthcare Investors (NYSE:HQH) Frequently Asked Questions

What stocks does MarketBeat like better than Tekla Healthcare Investors?

Wall Street analysts have given Tekla Healthcare Investors a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tekla Healthcare Investors wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Tekla Healthcare Investors?

Tekla Healthcare Investors saw a increase in short interest during the month of May. As of May 28th, there was short interest totaling 123,900 shares, an increase of 977.4% from the May 13th total of 11,500 shares. Based on an average trading volume of 152,200 shares, the short-interest ratio is presently 0.8 days.
View Tekla Healthcare Investors' Short Interest

How has Tekla Healthcare Investors' stock price been impacted by Coronavirus (COVID-19)?

Tekla Healthcare Investors' stock was trading at $17.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HQH shares have increased by 42.5% and is now trading at $25.47.
View which stocks have been most impacted by COVID-19

How often does Tekla Healthcare Investors pay dividends? What is the dividend yield for Tekla Healthcare Investors?

Tekla Healthcare Investors declared a quarterly dividend on Wednesday, May 19th. Stockholders of record on Friday, May 28th will be given a dividend of $0.50 per share on Wednesday, June 30th. This represents a $2.00 dividend on an annualized basis and a yield of 7.85%. The ex-dividend date is Thursday, May 27th.
View Tekla Healthcare Investors' dividend history

Is Tekla Healthcare Investors a good dividend stock?

Tekla Healthcare Investors pays an annual dividend of $1.98 per share and currently has a dividend yield of 7.72%. HQH has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Tekla Healthcare Investors' dividend history.

Who are Tekla Healthcare Investors' key executives?

Tekla Healthcare Investors' management team includes the following people:
  • Dr. Daniel R. Omstead M.S, Ph.D., Portfolio Mang. (Age 68)
  • Dr. Jason C. Akus M.D., MBA, VP of Research and Portfolio Mang.
  • Mr. Christopher F. Brinzey, Sr. VP of Research and Portfolio Mang.
  • Dr. Frank T. Gentile Ph.D., Sr. VP of Research and Portfolio Mang. (Age 59)

Who are some of Tekla Healthcare Investors' key competitors?

What other stocks do shareholders of Tekla Healthcare Investors own?

What is Tekla Healthcare Investors' stock symbol?

Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."

Who are Tekla Healthcare Investors' major shareholders?

Tekla Healthcare Investors' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Morgan Stanley (6.78%), Royal Bank of Canada (1.17%), Punch & Associates Investment Management Inc. (0.65%), UBS Group AG (0.65%), Claraphi Advisory Network LLC (0.35%) and Janney Montgomery Scott LLC (0.32%).
View institutional ownership trends for Tekla Healthcare Investors

Which major investors are selling Tekla Healthcare Investors stock?

HQH stock was sold by a variety of institutional investors in the last quarter, including Punch & Associates Investment Management Inc., 1607 Capital Partners LLC, Bank of Montreal Can, Advisors Asset Management Inc., Quantedge Capital Pte Ltd, Cohen & Steers Inc., Morgan Stanley, and Royal Bank of Canada.
View insider buying and selling activity for Tekla Healthcare Investors
or view top insider-selling stocks.

Which major investors are buying Tekla Healthcare Investors stock?

HQH stock was acquired by a variety of institutional investors in the last quarter, including Atlantic Union Bankshares Corp, Ameriprise Financial Inc., Barclays PLC, Commonwealth Equity Services LLC, Mercer Global Advisors Inc. ADV, Sigma Planning Corp, The PNC Financial Services Group Inc., and UBS Group AG.
View insider buying and selling activity for Tekla Healthcare Investors
or or view top insider-buying stocks.

How do I buy shares of Tekla Healthcare Investors?

Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tekla Healthcare Investors' stock price today?

One share of HQH stock can currently be purchased for approximately $25.47.

How much money does Tekla Healthcare Investors make?

Tekla Healthcare Investors has a market capitalization of $1.14 billion.

What is Tekla Healthcare Investors' official website?

The official website for Tekla Healthcare Investors is www.teklacap.com.

Where are Tekla Healthcare Investors' headquarters?

Tekla Healthcare Investors is headquartered at 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109.

How can I contact Tekla Healthcare Investors?

Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at 617-772-8500 or via email at [email protected]

This page was last updated on 6/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.